Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
24,205,802
-
Share change
-
+3,744,947
-
Total reported value
-
$121,270,575
-
Put/Call ratio
-
51%
-
Price per share
-
$5.01
-
Number of holders
-
54
-
Value change
-
+$18,717,135
-
Number of buys
-
26
-
Number of sells
-
17
Institutional Holders of FOAMIX PHARMACEUTICALS LTD - SHS (FOMX) as of Q2 2018
As of 30 Jun 2018,
FOAMIX PHARMACEUTICALS LTD - SHS (FOMX) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,205,802 shares.
The largest 10 holders included
GREAT POINT PARTNERS LLC, ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, BAKER BROS. ADVISORS LP, DSC Advisors, L.P., PERCEPTIVE ADVISORS LLC, AXA, Tekla Capital Management LLC, Vivo Capital, LLC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
54
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.